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Abstract
Acute respiratory distress syndrome (ARDS) is a poorly understood condition with greater than 30% mortality. Massive
recruitment of neutrophils to the lung occurs in the initial stages of the ARDS. Significant variability in the severity and
duration of ARDS-associated pulmonary inflammation could be linked to heterogeneity in the inflammatory capacity of
neutrophils. Interferon-stimulated genes (ISGs) are a broad gene family induced by Type I interferons. While ISGs are central
to anti-viral immunity, the potential exists for these genes to evoke extensive modification in cellular response in other
clinical settings. In this prospective study, we sought to determine if ISG expression in circulating neutrophils from ARDS
patients is associated with changes in neutrophil function. Circulating neutrophil RNA was isolated, and hierarchical
clustering ranked patients’ expression of three ISGs. Neutrophil response to pathogenic bacteria was compared between
normal and high ISG-expressing neutrophils. High neutrophil ISG expression was found in 25 of 95 (26%) of ARDS patients
and was associated with reduced migration toward interleukin-8, and altered responses to Staphylococcus aureus, but not
Pseudomonas aeruginosa, which included decreased p38 MAP kinase phosphorylation, superoxide anion release, interleukin-
8 release, and a shift from necrotic to apoptotic cell death. These alterations in response were reflected in a decreased
capacity to kill S. aureus, but not P. aeruginosa. Therefore, the ISG expression signature is associated with an altered
circulating neutrophil response phenotype in ARDS that may predispose a large subgroup of patients to increased risk of
specific bacterial infections.
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Introduction
The acute respiratory distress syndrome (ARDS) affects over
150,000 people per year, and is characterized by diffuse pulmonary
infiltrates on chest radiograph, severe hypoxia, and respiratory
failure with a mortality of 30–40%. Diverse insults are capable of
initiating ARDS including pneumonia, physical lung injury, sepsis,
and trauma. ARDS is distinguished by variability in susceptibility,
severity, and outcomes; however, mechanisms that account for this
variability are unclear. Known contributors to heterogeneity in
ARDS include demographic and clinical factors [1–3], and coding
variation in genes within the inflammatory response and coagula-
tion pathways [4,5]. For several of these mechanisms, the potential
predisposition towards developing ARDS is either present through-
out the life of the patient, or is a chronic conditionthat would not be
expected to resolve over time. However, ARDS rarely reoccurs
within an individual suggesting that mechanisms also exist that
sporadically place subjects at increased risk.
As massive accumulation of neutrophils to the lung is an early
feature of ARDS [6], heterogeneity in the inflammatory capacity of
the neutrophil could determine the extent, severity and duration of
pulmonary inflammation. In many neutrophil-mediated diseases,
the protective benefit of pathogen killing is balanced against the
considerable capacity of the cell to inflict tissue injury [7,8].
Dysregulation of neutrophil function in the inflammatory environ-
ment ofARDSissupportedby reportsofworse outcomesassociated
withelevated levels of neutrophil-relatedfactors inthe circulationor
airways [9–13], and functional changes in neutrophils from ARDS
patients [14–17]. Thus, much evidence suggests that both over-
exuberant and/or diminished responses by the innate immune
system can result in worse clinical outcomes in severely ill patients.
However, it is still not possible to predict which patients will exhibit
susceptibility to severe lung injury or neutrophil dysfunction.
Increasingly, it has become evident that neutrophils, and other
cells of the innate immune system, are capable of complex
‘‘adaptive’’ responses to pathogens by either decreasing (tolerance)
or increasing (priming) their response to challenges [18,19]. It now
seems clear that neither priming nor tolerance occur in isolation,
and a reprogramming of cellular phenotype is possible in response
to various sequences of infectious challenges [18,19].
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to Type I interferons, IFNa and IFNb [20], and include MX1,
ISG15 and IFIT1 [21]. Viral factors, intracellular bacteria, and
systemic autoimmune disorders evoke production of the IFNa/b
and ISGs [20]. However, ISG expression in the blood and
leukocytes serves as a well-validated marker of recent stimulation
by IFN a/b as a result of viral, but not bacterial, infection in vivo
[22–25]. Normally, ISG expression confers protection from
ongoing and subsequent viral infection [20]; however, the well-
recognized susceptibility to Staphylococcus aureus and other bacterial
infections following influenza infection suggests that post-viral
innate immunity is complex [26]. The possibility that ISG
expression could transiently affect neutrophil response has
received little attention, and the impact of ISG expression on
neutrophil responses to bacteria is not known. Moreover, the role
of ISG expression in ARDS patients has not been described.
We hypothesize that high ISG expression accompanies a
transient reprogramming of the circulating neutrophil phenotype
in the context of the inflammatory environment of ARDS, which
results in an impaired ability to kill pathogenic bacteria. Herein,
we show a subset of ARDS patients displayed elevated ISG
expression. Circulating neutrophils from ARDS patients with high
ISG expression demonstrated blunted activation of the p38 MAP
kinase (MAPk) cascade in response to S. aureus, and a decrease in
p38 MAPk-mediated responses. Of primary importance, high ISG
expression in neutrophils from ARDS patients also had reduced
killing of S. aureus, but not Pseudomonas aeruginosa. The neutrophil-
mediated inflammatory response to bacteria associated with ISG
expression has not been described previously, and highlights the
potential for previous viral infection to selectively impact specific
innate immune responses in ARDS.
Materials and Methods
Ethics Statement
The study protocol was approved by the Colorado Multiple
Institutional Review Board (COMIRB) committee and the
National Jewish Health Institutional Review Board; all subjects,
or an appropriate proxy, gave written informed consent. The
study was conducted in accordance with the Declaration of
Helsinki.
Subject enrollment and sample collection
Circulating neutrophils from ARDS patients were isolated from
whole blood obtained within 72 h of patients enrollment into one
of three NHLBI ARDS Network studies conducted at the
University of Colorado affiliated hospitals, each with identical
enrollment criteria. The parent studies were: Drug Study of
Albuterol to Treat ALI (ALTA, ClinicalTrials.gov Identifier:
NCT00434993), Early Versus Delayed Enteral Feeding and
Omega-3 Fatty Acid/Antioxidant Supplementation for Treating
PeopleWithALIorARDS(EDEN-Omega Study:NCT00609180),
or Early Versus Delayed Enteral Feeding to Treat People With ALI
or ARDS (The EDEN Study: NCT00883948). Sample processing
and data analysis was performed at NJH, with approval by the
National Jewish Health Institutional Review Board (HS-2342CO).
This ancillary trial was also registered in ClinicalTrials.gov
(Identifier: NCT00548795). The central inclusion criteria were that
within a 24-hour time period patients demonstrate an acute onset of
hypoxia (PaO2/FiO2#271 – adjusted for Denver altitude of
1600 m), bilateral infiltrates by chest radiograph, and requirement
for intubation and positive pressure ventilation in the absence of
evidence for left-sided cardiac failure. All patients enrolled into the
parentstudies were eligible forthis ancillary study,and selection was
not based on history or clinical evidence of recent or ongoing viral
infection. Diagnostic testing for acute or chronic viral infections was
performed on a limited basis in the context of clinical care, and not
as part of the study protocol.
Isolation of neutrophils and RNA
Human neutrophils were isolated from peripheral blood using
the plasma Percoll method [27]. RNA was extracted immediately
from 10220610
6 isolated neutrophils using TRIzol reagent [28].
Definition of high ISG expression
Gene expression was quantified by real-time PCR of MX1, IFIT1,
and ISG15 relative to GAPDH by the DCt method using standard
conditions. Primers and probes were obtained from Applied Bio-
Systems (MX1, Hs00182073_m1; ISG15; Hs00192713_m1; GAPDH
Endogenous Control) and Roche (IFIT1, Universal Probe Library
#9 and forward: 59-AGAACGGCTGCCTAATTTACA-39;r e -
verse: 59-GCTCCAGACTATCCTTGACCT-39). Expression of
each ISG was normalized to GAPDH expression, followed by log2
transformation. Identification of the high ISG expression cohort was
performed by hierarchical clustering using Multi Experiment Viewer
[29], using Euclidean distance analysis and the complete linkage
method.[29] To confirm assignment of samples, three-node k-means
clustering was performed, also using Multi Experiment Viewer. The
entire 25 subjects that were grouped by hierarchical clustering were
confirmed to be present in a single node by k-means clustering.
Bacterial cultures and killing
A clinical pulmonary isolate of a methicillin-sensitive S. aureus
was grown to 10
8 cfu/ml in tryptic soy broth, stored in aliquots of
15% glycerol in 0.9% saline and thawed immediately before use.
Pseudomonas aeruginosa (strain PAO1) was grown in overnight culture
in RPMI containing 2% heat-inactivated platelet-poor plasma
(HIPPP) and adjusted to an OD600 of 0.30 (corresponding to
5610
8 cfu/ml) before dilution. Neutrophil killing of S. aureus and
P. aeruginosa was determined by the growth of bacteria from wells
with neutrophils compared to growth of control wells of bacteria
without neutrophils. Briefly, 10
5 neutrophils in 100 ml RPMI
medium were allowed to settle for 30 min in duplicate wells of a
96-well plate. A bacteria-to-neutrophil ratio of 1:1 was contact-
synchronized by centrifugation at 110 g for 3 min. Control
reaction contained no neutrophils. Bacteria/neutrophil co-cultures
(or controls with only bacteria) were incubated at 37uC for 1 h.
Killing reactions were stopped with 1% Triton X-100, and
cultures were supplemented with 1X LB and 20 ml volume
alamarBlue reagent[30] in a final volume of 200 ml. Metabolic
oxidation was measured by alamarBlue reduction on a fluorescent
plate reader (Biotek FLX-800) at excitation of 540 nm and
emission of 600 nm; fluorescence was read at 30 min intervals at
37uC with continuous shaking for 14 h. Bacteria remaining in the
presence of neutrophils were determined by comparing bacterial
growth to that of a range of bacteria concentrations without
neutrophils and fit to a log-linear standard curve based on the time
to half-maximal growth.
Neutrophil functional and chemotaxis assays
Cells were resuspended in neutrophil medium (RPMI contain-
ing 2% HIPPP, and 10 mM HEPES, pH 7.6) or in Krebs-Ringer
phosphate-buffered saline with dextrose (KRPD; 154 mM NaCl,
5.6 mM KCl, 1.1 mM MgSO4, 2.2 mM CaCl, 0.85 mM
NaH2PO4, 2.15 mM Na2HPO4 and 0.2% dextrose) for individual
functional assays. A cytochrome c reduction assay for superoxide
anion (O2
2) release[31] was employed in neutrophils stimulated
Interferon-Stimulated Genes in ARDS PMN
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was determined by ELISA (ELISATech) [32] from 4.8610
6
neutrophils stimulated with each bacterial species (1:1 ratio) for a
range of times from 0 to 2 h. Neutrophil necrosis was determined
by the percent of total lactate dehydrogenase (LDH) released
(Cytotoxicity Detection Kit; Roche). Apoptosis was quantified by
immunoassay for cytoplasmic histone-associated DNA fragments
(Roche), and reported as an apoptosis index, the ratio of histone-
bound DNA in a given sample to the level of histone-bound DNA
detected in an equivalent number of cycloheximide-stimulated
circulatory neutrophils, which were .95% morphologically
apoptotic. Standard ELISA assays (ELISATech) were used to
quantify release of cytokines. Measurements of O2
2 release were
taken following 1 h, interleukin-8 (IL8) release following 2 h, TNF
release and cell death from apoptosis or necrosis were measured
at 4 h. Migration assays were performed on calcein-labelled
neutrophils for 1 h as described previously [32] and reported as
percent of total neutrophils migrating through the membrane.
Area-under-the-curve (AUC) was calculated for each migration
curve as an index of overall migration.
Data analysis
Data were analyzed using GraphPad Prism software. The
significance of the difference was assessed by non-parametric
Mann-Whitney U test for comparisons between normal ISG
expression and high ISG expression. To accurately depict the
extent of neutrophil variability, data is presented as individual data
points and median for the normal and high ISG groups. For all
tests, p,0.05 was considered significant.
Results
Anti-viral gene expression in circulating neutrophils
isolated from ARDS patients
Using three prototypical ISGs (MX1, ISG15, and IFIT1)a s
markers of overall ISG expression [33], relative expression levels
were determined by quantitative PCR. These three genes are a
feasible and representative sample of ISGs induced by Type I
interferons and viral infections, and are among the three most
highly expressed ISGs in human neutrophils [34,35] and other
leukocytes [23–25,33]. ARDS patients demonstrate variable
expression of MX1, ISG15, and IFIT1 (Figure 1). In order to
test phenotypic characteristics associated with high ISG expres-
sion, unsupervised hierarchical cluster analysis was performed to
classify these subjects. Hierarchical cluster analysis represents
an unbiased method to distinguish groups based on multiple
variables. Expression of each gene normalized to GAPDH
expression was log2 transformed and sorted by Euclidean distance
(see Methods). Two major clusters were delineated on the basis of
this analysis, termed ‘‘normal’’ and ‘‘high’’ ISG expression. The
high ISG cluster contained 25 of 95 subjects (26%) (Figure 1). An
independent method of grouping, k-means clustering, returned the
identical high ISG group (not shown). Expression values of each of
the three genes was significantly greater in the high group than the
normal group (MX1: 0.03660.055 vs 0.71960.553, p=9.46
10
215; ISG15: 0.00760.024 vs 0.35360.788, p=0.0003; IFIT1:
0.00660.011 vs 0.25560.259, p=2.1610
212; values are means 6
SD of the ISG/GAPDH ratio for normal vs high expressing
groups).
Demographic and clinical features of patients assigned to the
normal and high ISG cohorts were compared (Table 1). The age,
gender distribution, and proportion of ARDS patients presenting
with primary sepsis or pneumonia were not different (Table 1). As
expected, a significantly greater proportion of subjects in the high
ISG cohort were determined to have viral infections. However,
there was no difference in incidence of pre-existing conditions
associated with elevated ISG expression, including chronic
dialysis, immunosupression, and diabetes (Table 1).
ISG expression is associated with circulating neutrophil
dysfunction in ARDS
Circulating neutrophils responses previously implicated in the
pathogenesis of ARDS were examined following exposure to live
S. aureus, a gram-positive bacterium frequently identified in post-
viral infections, and to P. aeruginosa, an opportunistic Gram-
negative bacterium that causes secondary nosocomial infections in
critically ill patients. A broad functional phenotype of circulating
neutrophil response was tested in the context of normal and high
ISG expression.
IL8-induced Migration. Circulating neutrophils isolated
from patients with ARDS or sepsis have previously been
reported to demonstrate reduced migration [15]. In response to
IL8, neutrophils from ARDS patients with high ISG expression
demonstrated a reduction in migratory response compared to
ARDS neutrophils with normal ISG expression (Figure 2).
Activation of p38 MAPk. As a central intracellular signaling
mechanism of neutrophil stress responses, p38 MAPk regulates
O2
2 release, apoptosis, migration, and cytokine production to
inflammatory stimuli [36,37]. Dual phosphorylation of p38 MAPk
correlates with kinase activity. Bacterial-induced p38 MAPk
activation was quantified as an area under the curve (AUC) of
stimulated phosphorylation over a 2-hour exposure to the bacteria
(Figure 3). In response to S. aureus, neutrophils isolated from
ARDS patients with high ISG expression had significantly
attenuated p38 MAPk activation compared to those with normal
ISG expression (Figure 3C). Unstimulated p38 MAPk activation
was not different between high and normal ISG expression
(Figure 3A,B). Compared to S. aureus, exposure to P. aeruginosa
induced less p38 MAPk activation under the conditions studied,
and no difference was seen between normal and high ISG-
expressing groups (Figure 3D).
Superoxide anion release. The release of superoxide anion
(O2
2) by circulating neutrophils from ARDS patients was tested in
response to S. aureus and P. aeruginosa (Figure 4). Neutrophils
isolated from ARDS patients with high ISG expression
spontaneously produced significantly less O2
2 than normal ISG
expressing cells (Figure 4A) and in response to S. aureus
(Figure 4B). O2
2 release in response to P. aeruginosa was not
different between groups of neutrophils (Figure 4C). Phorbal
myristate acetate, a potent activator of reactive oxygen
intermediate production, induced similar levels of O2
2 release in
both groups (data not shown), suggesting that the potential to
release O2
2 has remained intact, independent of ISG expression.
Cytokine production. Neutrophil release of IL8 and TNF
was tested following exposure to S. aureus and P. aeruginosa. Both
bacteria stimulated significant release of IL8 and TNF over non-
stimulated neutrophils (data not shown). Reduced secretion of IL8
was observed by circulating neutrophils isolated from ARDS
patients with high ISG expression in response to S. aureus
(Figure 5A), but no difference in IL8 release was observed in
response to P. aeruginosa (Figure 5B). In contrast, high ISG-
expression was not associated with alterations in TNF release
following exposure to S. aureus or P. aeruginosa (Figure 5C,D),
indicating that the ability to secrete cytokines is not universally
impaired in ISG-expressing neutrophils.
Neutrophil death. Pathways leading to cell death have a
complex effect on inflammation and pathogen killing by the short-
lived neutrophil. While necrotic death is implicated in airway
Interferon-Stimulated Genes in ARDS PMN
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21958Figure 1. ARDS patients include a cohort of individuals with elevated neutrophil ISG expression. Expression of neutrophil MX1, IFIT1, and
ISG15 were determined by real-time PCR and normalized to expression of GAPDH. Log2-transformed, normalized ISG levels were ordered by hierarchical
clustering, with the primary clusters designated as either high or normal ISG expression. The dotted line indicates the separation of the normal and high
ISG groups. Individual ARDS patients (Pt) are indicated. The difference between the cohorts was highly significant as indicated in the text. (A) The heat-
map indicates the range of log2-transformed data. (B) Non-transformed data is aligned to the clustering results for an alternative visualization.
doi:10.1371/journal.pone.0021958.g001
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inflammatory response [38]. In addition, highly virulent strains
of S. aureus have been identified which evoke neutrophil lysis
following phagocytosis [39,40]. Circulating neutrophils from
ARDS patients with high ISG expression had significantly less
necrotic cell death following 4 h exposure to S. aureus (Figure 6B),
but necrotic cell death was not changed in response to P. aeruginosa
(Figure 6C), or when unstimulated (Figure 6A).
An opposite pattern was observed in analysis of apoptosis.
Circulating neutrophils from ARDS patients with high ISG
expression demonstrated greater apoptotic cell death following 4 h
exposure to S. aureus (Figure 6E); however, no change was
observed in unstimulated cells or following exposure to P. aeruginosa
(Figure 6D,F). Together, Figure 6 demonstrates that high ISG
expression in neutrophils treated with S. aureus from ARDS
patients has an overall effect of enhancing apoptosis and reducing
necrosis. Furthermore, an interaction between type of cell death
and ISG expression was evident for S. aureus-( p ,0.01) and P.
aeruginosa-treated (p,0.05) neutrophils when tested by two-way
ANOVA. Total cell death, as assessed by adding the percentage of
cells undergoing necrosis and apoptosis, was not different for any
condition (data not shown).
Bacterial killing. Reduced p38 MAPk activation and O2
2
release, combined with enhanced apoptosis, suggests that high ISG
expression may be associated with reduced bactericidal capacity of
these neutrophils. We assayed survival of bacteria in the presence
of neutrophils to determine bactericidal activity, which includes
phagocytic and non-phagocytic killing pathways. Circulating
neutrophils from ARDS patients that expressed normal ISG
levels killed S. aureus efficiently, while high ISG expression was
associated with impaired bactericidal ability (Figure 7A). Killing
of P. aeruginosa was not reduced in high-ISG expressing neutrophils
(Figure 7B).
Discussion
This study is the first known exploration of the role of neutrophil
ISG expression in ARDS. ISGs were first identified as a
consequence of Type I interferon activation of cells. Detection of
virus or viral products leads to IFNa/b release, but may occur also
Table 1. Study Population.
Cohort (n) Age (yrs) Males (%)
Viral Infection
1
(%)
Sepsis or
pneumonia (%)
Chronic
dialysis (%)
Immuno-
compromised (%) Diabetes (%)
ARDS Patients
Median (range)
95 52.0 (21–86) 52.6 15.8 77.9 4.2 4.2 28.4
Normal ISG Median
(range)
70 52.5 (21–82) 54.3 8.6 75.7 4.3 1.4 28.6
High ISG Median
(range)
25 50.0
NS (21–86) 48.0
NS 36.0
2 84.0
NS 4.0
NS 12.0
NS 28.0
NS
1Viral Infection: Confirmed Influenza A, HIV, acute HSV, or Hepatitis C.
NSNot Significantly different than subjects in the normal ISG cohort.
2p=0.003 Fisher’s Exact Test (2-Tail).
doi:10.1371/journal.pone.0021958.t001
Figure 2. High ISG expression is associated with reduced circulating neutrophil migration in ARDS patients. (A) Directional migration
towards IL8 was measured in isolated neutrophils with a modified Boyden chamber system over 60 minutes and (B) AUC of migration curves shown
in (A); ARDS patients with high ISG expression (ISG; red; n=20) were found to have reduced migration compared to those with normal ISG expression
(black; n=58). Bar and whiskers indicate median, 25
th- and 75
th-percentile, and range. *, p,0.05.
doi:10.1371/journal.pone.0021958.g002
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PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e21958Figure 3. S. aureus-induced p38 MAP kinase activity is attenuated in circulating neutrophils with high ISG expression. Time-course of
phospho-p38 MAPk phosphorylation induced by (A) S. aureus,o r( B) P. aeruginosa was measured by ELISA at 6 time points over 2 hours; stimulated
(closed symbols) or unstimulated neutrophils (open symbols) and either normal (black; upper panels) or high ISG expression (red; lower panels). The
shaded portion indicates the DAUC. Mean 6 SEM is shown. Phospho-p38 MAPk DAUC values from a phospho-p38 MAPk time-course were
determined in neutrophils in response to (C) S. aureus, and (D) P. aeruginosa with normal (black) and high ISG expression (red). Median values are
indicated by the like-colored bars; ARDS normal ISG (n=58 in panels A and C, and 49 in panels B and D), ARDS high ISG (n=22 in panels A and C, and
18 in panels B and D). *, p,0.05.
doi:10.1371/journal.pone.0021958.g003
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Subsequent induction of ISGs conveys the anti-viral capacity of
IFNa/b by producing gene products affecting viral replication and
release, and inflammatory and immunomodulatory cytokines
[20,21]; however, this diverse gene family likely has broader
immunomodulatory effects [42–45]. To determine if ISG
expression alters neutrophil function in ARDS patients we
interrogated a three-gene panel of ISGs, previously shown to be
highly expressed in stimulated neutrophils [34,35,46], lymphocytes
[23], peripheral blood mononuclear cells [24,25], and whole blood
[33]. Our analysis indicates that approximately three-quarters of
ARDS patients have negligible upregulation of ISG, while a
quarter have robust ISG expression. Unsupervised hierarchical
clustering of MX1, ISG15, and IFIT1 expression objectively
defined in an unbiased manner a distinct high ISG-expressing
group. A second, independent clustering approach returned an
identical group.
We hypothesized that the immunomodulatory effect associated
with elevated ISG expression may extend to circulating neutrophil
responses in ARDS. Neutrophils from ARDS patients were
analyzed for a series of functional responses to live bacteria that
may be clinically and mechanistically relevant to the syndrome.
Interestingly, neutrophils from ARDS patients with elevated ISGs
were less adept at killing a Gram-positive bacterium, S. aureus, but
not a Gram-negative bacterium, P. aeruginosa. A mechanistic basis
for impaired bacterial killing may in part be linked to attenuation
of O2
2 generation, which is especially important for successful
eradication of S. aureus [47]. Our killing assay measures the
summation of all possible killing mechanisms, and further study is
needed to assign a specific mechanism to this effect. Furthermore,
high ISG expression was found to shift neutrophils towards
apoptotic cell death and away from necrotic cell death (Figure 6).
Intriguingly, highly virulent strains of S. aureus are capable of
evoking significant post-phagocytic necrosis over time periods
longer than what was studied in this report [39,40]. Apoptotic cells
are associated with anti-inflammatory potential [38], and therefore
may restrain beneficial effects of other cells. IFNa/b have been
shown to sensitize a number of cell types to apoptosis following
bacterial infection, as seen in Listeria infected murine macrophages
[48]. Thus, our data showing enhanced apoptosis following
bacterial infection of ISG-expressing neutrophils extends this
phenomenon to human cells. Furthermore, neutrophil extracellu-
lar trap (NET)-mediated cell death was not addressed, although
IFNa acutely sensitizes neutrophils to NET formation [49].
Further evidence of an impaired circulating neutrophil
phenotype associated with high ISG expression comes from
studies of migration, cytokine release, and p38 MAP kinase
activation. Neutrophils from ARDS patients have reduced
migration compared to healthy controls [15](data not shown),
and migration was further worsened in cells with high ISG
expression. In addition, IL8 secretion from S. aureus-treated
neutrophils was selectively reduced in the high ISG group, while
TNF release was not altered, supporting the conclusion that the
decrease in IL8 release was not a nonspecific effect of reduced
neutrophil viability. As with O2
2 release, neutrophil migration
and release of IL8 are dependent on p38 MAPk activation [37].
Accordingly, we detected suppression of p38 MAPk activation by
S. aureus in neutrophils with high ISG expression.
The more pronounced effect of high ISG expression of ARDS
neutrophils in response to S. aureus than P. aeruginosa may form a
framework for a difference in susceptibility to various post-
influenza infections. Clinical data and animal models demonstrate
Figure 4. Superoxide anion release is suppressed in neutrophils expressing ISG. Release of superoxide anion (O2
2N) from neutrophils
following 60 minutes incubation. (A) Spontaneous; (B) S. aureus-induced; and (C) P. aeruginosa-induced release of O2
2N. ARDS patients demonstrated
significant attenuation of O2
2N release when ISG expression was elevated in non-stimulated and S. aureus-stimulated neutrophils. Scatter plot of
values in neutrophils with normal (black) and high ISG expression (ISG; red); normal ISG (n=65 in panels A and B, and 55 in panel C), high ISG (n=23
in panels A and B, and 17 in panel C). *p,0.05, **, p,0.01.
doi:10.1371/journal.pone.0021958.g004
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PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e21958Figure 5. S. aureus-induced IL8 release is reduced in high ISG-expressing neutrophils from ARDS patients. Release of IL8 following 2 h
incubation with (A) S. aureus, and (B) P. aeruginosa. TNF release following 4 h incubation with( C) S. aureus, and (D) P. aeruginosa. Cytokine release
from neutrophils with normal (black) and high ISG expression (ISG; red) are shown; normal ISG (n=52 in panels A and C and 42 in panels B and D),
high ISG (n=19 in panels A and C and 14 in panels B and D); *p,0.05.
doi:10.1371/journal.pone.0021958.g005
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infections [26,50,51], even in the presence of neutrophil-rich
inflammation. The classic scenario of post-viral S. aureus
pneumonia is familiar to clinicians [26], whereas P. aeruginosa has
not been implicated in this setting.
Neutrophils are known to respond to IFNa with STAT
phosphorylation and upregulation of ISGs [28,35,46,52]. Inter-
estingly, neutrophils are a major contributor of ISG expression in
LPS-exposed whole murine lung [53]. Wright et al. [35] reported
the reversible induction of ISGs in neutrophils during periodontitis
associated with enhanced reactive oxygen intermediate produc-
tion. Other investigators have demonstrated inhibition of apop-
tosis and enhanced reactive oxygen intermediate production in
neutrophils treated acutely with IFNa/b [52,54–56]. Although the
exact mechanism is unknown, neutrophil dysfunction may derive
from the activities of the diverse ISG products that establish an
anti-viral phenotype, which possibly have additional effects in
combination with the potent inflammatory environment of ARDS.
Although we have no data to support a causal role of ISG
expression in neutrophil dysfunction in ARDS, several studies
Figure 6. Reciprocal modification of cell death in neutrophils from ARDS patients expressing ISG. (A–C) The release of LDH to assess
necrosis, and (D–F) percent of soluble histone-associated DNA fragments to assess apoptosis, from isolated neutrophils after 4 h treatment. (A)
Spontaneous necrosis. (B) S. aureus-induced necrosis. (C) P. aeruginosa-induced necrosis. (D) Spontaneous apoptotic cell death (E) S. aureus-induced
apoptotic cell death. (F) P. aeruginosa-induced apoptotic cell death. Scatter plot of values in neutrophils with normal (black) and high ISG expression
(ISG; red); median values are indicated by the like-colored bars; normal ISG (n=50–63), high ISG (n=17–22). *, p,0.05, **, p,0.01.
doi:10.1371/journal.pone.0021958.g006
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activity. Difficulties in testing this hypothesis in neutrophils include
reproducing the developmental stage and the already highly
activated state of ARDS neutrophils, and in genetically altering
neutrophils. However, ubiquitin-like ISG15 modifies proteins [57],
including signaling proteins, and the ability of secretory murine
ISG15 to act as a neutrophil chemoattractant suggests an
inflammatory role [58]. Anti-bacterial mechanisms are not defined
for MX1, which codes for a dynamin-like GTPase that may
interfere with viral assembly [59], while IFIT1 inhibits translation
by interacting with eukaryotic initiation factor 3 [60]. These
particular ISGs may play a part an anti-bacterial role, or be
upregulated in coordination with other ISGs directly responsible
for the effect. Alternatively, neutrophil dysfunction may be
mechanistically independent of ISGs. The ability of Type I
interferons to regulate anti-bacterial activity is beginning to be
appreciated. Ifnb
2/
2 and Ifnar1
2/
2 mice are more susceptible to
Streptococcal infection, although Ifnar1
2/
2 mice are protected from
infection by Listeria, Chlamydia and in polymicrobial sepsis [42–45].
Thus, immunomodulation by IFNa/b may depend on the specific
infection. We are unaware of studies determining the role of Type
I interferons on neutrophils or in human disease in response to S.
aureus or P. aeruginosa, but our data suggest that IFNa/b signaling
results in an impairment of neutrophil bactericidal activity
specifically to S. aureus. Likewise, the dysfunctional properties of
ISG-expressing neutrophils in response to live bacteria may
predict similar dysfunction in response to other inflammatory
factors, which could contribute to the acute organ failure
prominent in ARDS.
In the majority of patients the source of ISG induction has not
been identified. These initial experiments were designed to
determine only the effect of ISG expression with neutrophil
functional responses. In the course of clinical care, a significantly
greater fraction of subjects were identified as having serious vial
infections in the high ISG cohort (Table 1). But high ISG
expression was not associated with sepsis or pneumonia (Table 1).
Future studies are warranted to systematically screen for viral
infections in this population. Recently, Limaye et al. [61] observed
cytomegalovirus reactivation in critically ill patients, although
notably, detection occurred one to two weeks after hospitalization,
while our samples were collected within 72 h.
The functional response of neutrophils to any chosen stimulus is
remarkably variable. Differences in neutrophil functional respons-
es [9,12,14,15,17] and in mechanistically relevant molecules
[10,11] have been described previously in ARDS patients as a
whole, yet variability in presentation, severity, and response to
therapy remain poorly understood. The data presented here
suggest that ISG expression could underlie, in part, variability in
ARDS. The battery of cytokines, damage-associated molecular
patterns, and other pro-inflammatory insults intrinsic to ARDS
may modify the response phenotype mediated by ISG upregula-
tion. Therefore, high ISG expression may represent a ‘‘first hit’’
Figure 7. High ISG expression is associated with impaired neutrophil killing of S. aureus in ARDS. Killing of (A) S. aureus and (B) P.
aeruginosa. Bacteria were exposed to adherent neutrophils for 60 min, and bacteria remaining was compared to that in the absence of neutrophils to
determine percentage of bacteria killed. Values less than zero indicate growth of bacteria during the assay. ISG expression was associated with an
impaired bactericidal activity against S. aureus, but not against P. aeruginosa. Scatter plot of values in neutrophils with normal (black) and high ISG
expression (ISG; red); median values are indicated by the like-colored bars; normal ISG (n=54 in panel A, and 49 in panel B), ARDS high ISG (n=19 in
panel A, and 15 in panel B); *, p,0.05.
doi:10.1371/journal.pone.0021958.g007
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diminishes neutrophil responses. Thus, our data suggest that the
altered-response phenotype associated with elevated ISG expres-
sion should be considered along with genetic, environmental, and
complex demographic factors as a contributor to heterogeneity of
neutrophil response in ARDS. Further studies targeting the Type I
interferon pathway may identify specific molecular mechanisms of
neutrophil dysfunction in ARDS. Studies are currently underway
to analyze neutrophil ISG expression as a marker of ARDS
outcome, and the role of high ISG expression in other neutrophil-
mediated diseases.
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